Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Aug 29, 2024

BUY
$13.2 - $17.76 $375,183 - $504,792
28,423 New
28,423 $504,000
Q4 2023

Aug 29, 2024

BUY
$6.52 - $20.32 $185,317 - $577,555
28,423 New
28,423 $534,000
Q4 2023

Feb 28, 2024

BUY
$6.52 - $20.32 $185,317 - $577,555
28,423 New
28,423 $534,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.3B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track University Of Texas Portfolio

Follow University Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of University Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on University Of Texas with notifications on news.